Istrabenz, d.d., announced today it continues to evaluate a variety of potential opportunities directed at maximizing shareholder value through a potential divestiture of its holding in the food and beverage group Droga Kolinska. The company has received numerous non-binding offers and will focus on executing Droga Kolinska’s current business plan while simultaneously working closely with its financial advisor BNP Paribas to review the options and carry out further stages of the process. The company does not expect to publicly disclose additional information regarding the status of the review. There can be no assurances that any particular course of action will be pursued or as to the timing or terms of any transaction.
 

 

Management Board
of the holding company Istrabenz, d.d.